PAPER Barber R
SEARCH RESULTS
329963 RESULTS
PAPER Wint D
Depression: a shared risk factor for cardiovascular and Alzheimer disease.
Cleve Clin J Med. 2011 Aug;78 Suppl 1:S44-6. PubMed: 21972330PAPER Grammas P, Sanchez A, Tripathy D, Luo E, Martinez J
Vascular signaling abnormalities in Alzheimer disease.
Cleve Clin J Med. 2011 Aug;78 Suppl 1:S50-3. PubMed: 21972332Toward a New Research Agenda in Alzheimer’s Disease
CONFERENCE COVERAGE SERIES From Australia, Impulse for a New Alzheimer’s Research Agenda Australia Report: Genetics and Aging Australia Report: Protein Aggregation, Selective Vulnerability, Spreading Australia Report: Aβ Toxicity, ApoE Australia Report: Inflammation Australia Repor
Tiernan O'Malley
BiogenCambridge, United States
PAPER Maret S, Faraguna U, Nelson AB, Cirelli C, Tononi G
Sleep and waking modulate spine turnover in the adolescent mouse cortex.
Nat Neurosci. 2011 Nov;14(11):1418-20. PubMed: 21983682PAPER Bushey D, Tononi G, Cirelli C
Sleep and synaptic homeostasis: structural evidence in Drosophila.
Science. 2011 Jun 24;332(6037):1576-81. PubMed: 21700878PAPER Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V, Mastrapasqua M, Frigeri A, Amato MP, Hakiki B, Ghezzi A, Lugaresi A, De Luca G, Patti F, D'amico E, Sola P, Simone AM, Svelto M, Livrea P, Trojano M
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1355-9. PubMed: 21622936PAPER Tsai GC, Stauch-Slusher B, Sim L, Hedreen JC, Rothstein JD, Kuncl R, Coyle JT
Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS.
Brain Res. 1991 Aug 9;556(1):151-6. PubMed: 1682006PAPER Simone IL, Ruggieri M, Tortelli R, Ceci E, D'Errico E, Leo A, Zoccolella S, Mastrapasqua M, Capozzo R, Livrea P, Logroscino G
Serum N-acetylaspartate level in amyotrophic lateral sclerosis.
Arch Neurol. 2011 Oct;68(10):1308-12. PubMed: 21987545June Kaplow
Eisai Inc.Woodcliff Lake, United States
Gabor G. Kovacs
University of Toronto Toronto, Canada
Andreas Müller-Schiffmann
Heinrich-Heine-University DüsseldorfDüsseldorf, Germany
Aβ Antibody Gantenerumab Clears Plaques
RESEARCH NEWS 2011-10-14 Research News Another antibody joins the ranks of those reported to clear Aβ from the brains of patients with mild to moderate Alzheimer's disease. Gantenerumab, a human monoclonal antibody, clears plaques in a matter of months, report scientists at
Australia Report: The Way Forward—Pre-symptomatic Trials
CONFERENCE COVERAGE 2011-10-14 Conference Coverage Over the past five years, the field at large has reached strong consensus that clinical trials should treat people earlier. This should start with defined populations whose genotype, age, and/or biomarker status unquestionably put them
Current Filters
No filters selected